At the end of the latest market close, AzurRx BioPharma Inc. (AZRX) was valued at $0.85. In that particular session, Stock kicked-off at the price of $0.80 while reaching the peak value of $0.81 and lowest value recorded on the day was $0.7661. The stock current value is $0.79.
Recently in News on April 13, 2021, AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis. Phase 1b/2a Study Expected to Begin In 2Q 2021. You can read further details here
AzurRx BioPharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.6300 on 01/22/21, with the lowest value was $0.7661 for the same time period, recorded on 04/13/21.
AzurRx BioPharma Inc. (AZRX) full year performance was 23.07%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AzurRx BioPharma Inc. shares are logging -69.80% during the 52-week period from high price, and 41.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.56 and $2.63.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2611883 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AzurRx BioPharma Inc. (AZRX) recorded performance in the market was -18.11%, having the revenues showcasing -13.90% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 60.81M, as it employees total of 12 workers.
Analysts verdict on AzurRx BioPharma Inc. (AZRX)
During the last month, 0 analysts gave the AzurRx BioPharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1673, with a change in the price was noted +0.0938. In a similar fashion, AzurRx BioPharma Inc. posted a movement of +13.39% for the period of last 100 days, recording 6,335,458 in trading volumes.
AzurRx BioPharma Inc. (AZRX): Technical Analysis
Raw Stochastic average of AzurRx BioPharma Inc. in the period of last 50 days is set at 2.20%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.58%. In the last 20 days, the company’s Stochastic %K was 1.91% and its Stochastic %D was recorded 2.03%.
Let’s take a glance in the erstwhile performances of AzurRx BioPharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -18.11%. Additionally, trading for the stock in the period of the last six months notably improved by 2.45%, alongside a boost of 23.07% for the period of the last 12 months. The shares increased approximately by -20.43% in the 7-day charts and went up by -41.60% in the period of the last 30 days. Common stock shares were lifted by -13.90% during last recorded quarter.